Biotech Co.*

Pharma Co.

Product

Disclosed

Terms/Details

(Symbol)

(Country)

Funding

(Date)

($M)


Antares
Pharma
Inc.
(ANTR)

Pharmacia
Corp.

Undisclosed product

ND

Antares granted Pharmacia exclusive sales and marketing rights for the product in certain European territories; the product will use Antares' transdermal gel technology delivery system (5/1)

Cephalon
Inc.
(CEPH)

Armstrong Laboratories
de Mexico S.A.C.V.
(Mexico) and
Sintong Chemical
Industrial Co.
Ltd. (Taiwan)

Modafinil

ND

Agreement gives Armstrong and Sintong territorial rights to market and distribute modafinil, which Cephalon markets in the U.S. as Provigil (5/24)

Cephalon
Inc.
(CEPH)

Orphan
Australia Pty.
Ltd. (Australia)

Actiq

ND

Cephalon granted Australian and New Zealand sales, marketing and distribution rights for Actiq to Orphan Australia (6/12)

Cephalon
Inc.
(CEPH)

Ricercas
LLC*

Angiogenesis inhibitor to treat solid tumors

ND

Ricerca will produce kilogram quantities of the active pharmaceutical ingredient for use in Phase I studies (3/30)

Cepheid
Inc.
(CPHD)

BioSynTech
Sdn Bhd
(Malaysia)

Smart Cycler system

ND

BioSynTech will market the system, accessories and consumables in the life science research markets in Malaysia and Singapore (6/14)

Chiron Corp.
(CHIR)

F. Hoffmann-
La Roche Ltd.
(Switzerland)

HIV-1 and hepatitis C virus intellectual property

ND

Roche gains a license to manufacture and sell probe-based HIV-1 and HCV blood screening tests worldwide (5/23)

Compugen
Inc. (CGEN)

Sigma-
Genosys

OligoLibraries

ND

Compugen will provide the content and designs of the OligoLibraries, which will provide access to oligonucleotide collections representing genomes of various organisms for high-throughput analysis of gene function; Sigma-Genosys will manufacture the products (6/26)

Dendreon
Corp.
(DNDN)

Covance
Biotechnology
Services Inc.
(subsidiary of
Covance Inc.)*

Provenge

ND

Covance will produce antigen to prepare Provenge for the market (4/5)

Dragon
Pharmaceuticals
Inc.
(Canada;
OTC BB:DRUG)

Transworld Pharmaceuticals
Corp. (Portugal)
and Renapharm
AB (Sweden)

Formulation of erythropoietin

ND

Agreement giving Dragon sole worldwide manufacturing rights and exclusive marketing rights in Asia to a novel, slow-release formulation of erythropoietin; Transworld will have exclusive marketing rights outside Asia (6/19)

Dyax Corp.
(DYAX)

Wyeth-Genetics
Institute (unit of
American Home
Products Corp.)

Chemically
sizeable ligand

ND

Commercial license for the ligand, which has a high capacity and specificity for purification of Wyeth-Genetics' Factor VIII product, ReFacto (5/22)

Nexell
Therapeutics

Inc.
(NEXL)

Baxter
Healthcare
Corp.

Cell-processing products, including Isolex 300i Magnetic Cell Selection System

ND

Nexell signed a letter of intent to transfer exclusive worldwide rights for sales, marketing and distribution of its cell-processing products to Baxter (6/12)

Proteome
Systems Inc.
(Australia)*

Sigma-Aldrich
Corp.

ProteoPrep and other products

ND

The products include ProteoPrep, a line of sample preparation kits; agreement grants Sigma-Aldrich manufacturing and distribution rights to products developed in the collaboration (5/7)

StemCell
Technologies

Inc.
(Canada)*

Applied
Imaging Corp.

RosetteSep tumor enrichment products and technology

ND

StemCell will supply RosetteSep tumor enrichment products and technology and Applied Imaging will market and sell the products (5/3)

The Medicines
Co.
(MDCO)

Grupo Ferrer
Internacional
SA (Spain)

Angiomax

ND

Collaboration for the registration, distribution and promotion of Angiomax in Spain, Portugal, Greece and 18 Latin American markets (6/5)

The Medicines
Co.
(MDCO)

Medison
Pharma Ltd.
(Israel)

Angiomax

ND

Exclusive marketing and distribution agreement for the registration, distribution and promotion of Angiomax in Israel (5/21)


NOTES

# The information in the chart does not cover agreements between biotech companies or agricultural agreements. The chart may include collaborations that occurred prior to April 26, but were not listed in the previous chart.

* Private companies are indicated with an asterisk; unless otherwise noted, stock symbols listed are on the NASDAQ market.

** Denotes the date the item ran in BioWorld International.

ND = Not disclosed, reported and/or available

AMEX = American Stock Exchange; ASX = Australian Stock Exchange; CSE = Copenhagen Stock Exchange; LSE = London Stock Exchange; NYSE = New York Stock Exchange; OTC BB = Over The Counter Bulletin Board; TSE = Toronto Stock Exchang; VSE = Vancouver Stock Exchange.

No Comments